Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2020-10-12 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于实际控制人股份质押延期购回的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the extension of the repurchase period for pledged shares by its actual controller. It details the number of shares pledged, the pledge start and extended end dates, and the shareholder's background. There is no financial statement, earnings data, or management discussion. The content focuses on share pledge and repurchase extension, which relates to capital structure and financing activities. The document length is short (1536 characters), and it is a direct announcement of a financing-related event, not a report or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-10-12 Chinese
关于公司产品获得CE认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a product obtaining CE certification, which is a regulatory approval for medical devices in the European Union. It includes details about the product and its clinical use, and discusses the potential market impact. The document is short (812 characters) and does not contain financial statements, earnings data, or detailed financial analysis. It is not a report like an Annual Report, Interim Report, or Earnings Release. It is also not a regulatory filing about shareholding, management changes, or legal matters. The content is an announcement about a product certification, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-10-12 Chinese
关于参股公司拟申请其股票在全国中小企业股份转让系统终止挂牌的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company (迪瑞医疗科技股份有限公司) regarding a significant event related to its investee company (致善生物) applying to terminate its stock listing on the National SME Share Transfer System. The document includes details about the board meeting, shareholder approval pending, and the potential impact on the company. It is a regulatory announcement about a corporate event, not a financial report, earnings release, or management discussion. The document is short (621 characters) and serves as an official notice of a corporate action. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-09 Chinese
关于公司高级管理人员提前终止减持计划的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the early termination of a share reduction plan by senior management personnel of the company. It details the shareholding changes of two executives, their planned and actual share sales, and confirms compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on insider share transactions by company directors and executives. Therefore, this document fits the category of Director's Dealing (DIRS). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2020-09-24 Chinese
关于公司产品获得CE认证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company (迪瑞医疗科技股份有限公司) regarding its products obtaining CE certification. It lists detailed product information and explains the significance of the certification for market access and competitive advantage. There is no financial data, no mention of financial results, no regulatory filings about management or board changes, no voting results, no legal proceedings, no capital or financing updates, and no mention of any report being attached or published. The document is a regulatory announcement about product certification, which does not fit into financial report categories like Annual Report, Interim Report, Earnings Release, or others. It is a general regulatory announcement about product certification compliance and market access. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-09-23 Chinese
关于公司医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about changes to its medical device registration certificates issued by a regulatory authority (国家药品监督管理局 - National Medical Products Administration). It details specific product registration certificate changes, including packaging and applicable device models. The document is short (1736 characters) and focuses on regulatory approval updates rather than financial data or corporate governance. It does not contain financial statements, earnings data, or management discussion. It is not a report but an announcement of regulatory changes related to product registrations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-22 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.